Evidence-informed actives & dosages; excipient strategy; allergen constraints.
Formats: capsules, powders (others case-by-case)
Flavor systems & sweeteners (for powders)
Label design & printing aligned to the final formula and claims
Compliance review for panel & copy (FDA/FTC-aligned)
MOQ: typically ≥ 2000; may be higher for certain formats/flavors.
Timing: add ~1–3 weeks for R&D/pilot on top of production timeline.
Docs: Spec Sheet + QA Release + QC Summary; COA under NDA (redacted/view-only) or third-party retest.




Quality statement: Manufactured in US GMP-certified, FDA-registered & inspected facilities. Standard documentation includes Batch QC Summary, QA Release Letter, and Finished Product Specifications. COA access under NDA (redacted) or third-party retest available upon request.
Copyright © 2025 Quanture Nutraceuticals - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.